Načítá se...
Serum N‐glycome alterations in breast cancer during multimodal treatment and follow‐up
Using our recently developed high‐throughput automated platform, N‐glycans from all serum glycoproteins from patients with breast cancer were analysed at diagnosis, after neoadjuvant chemotherapy, surgery, radiotherapy and up to 3 years after surgery. Surprisingly, alterations in the serum N‐glycome...
Uloženo v:
| Vydáno v: | Mol Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5623820/ https://ncbi.nlm.nih.gov/pubmed/28657165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12105 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|